CERS · Company research

Cerus Corp (CERS): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

16records availableHealthcare

Stock News & Events data

Database-backed records only

16 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
A workshop will share one hospital's experience using treated platelets and a clotting product - Stock TitanA workshop will share one hospital's experience using treated platelets and a clotting product Stock TitanView source ↗Stock TitanOct 14, 2026neutral00.6
Cerus Corporation (CERS) - What Are Analysts Saying About This Stock? - MarketBeatCerus Corporation (CERS) - What Are Analysts Saying About This Stock? MarketBeatView source ↗MarketBeatOct 14, 2026neutral00.6
Cerus Corporation (CERS) Slips 1.74% to $2.26 as Shares Drift Toward Support - Pullback Trade - https://www.dars.gov.et/Cerus Corporation (CERS) Slips 1.74% to $2.26 as Shares Drift Toward Support - Pullback Trade https://www.dars.gov.et/View source ↗https://www.dars.gov.et/Oct 13, 2026neutral00.6
Cerus Corp. Stock Grades | CERS - Barron'sCerus Corp. Stock Grades | CERS Barron'sView source ↗Barron'sOct 6, 2026neutral00.6
Cerus: This Blood-Safety Underdog Should Be Earning More Respect (NASDAQ:CERS) - Seeking AlphaCerus: This Blood-Safety Underdog Should Be Earning More Respect (NASDAQ:CERS) Seeking AlphaView source ↗Seeking AlphaAug 18, 2026neutral00.6
Cathie Wood's investment moves on August 17! Expanding investments in blood safety and AI infrastructure, shifting funds from positions in Roblox and biotech stocks to CERS and NVDA - MoomooCathie Wood's investment moves on August 17! Expanding investments in blood safety and AI infrastructure, shifting funds from positions in Roblox and biotech stocks to CERS and NVDA MoomooView source ↗MoomooAug 18, 2026neutral00.6
Cerus (NASDAQ: CERS) insider moves to sell more stock after July sale - Stock TitanCerus (NASDAQ: CERS) insider moves to sell more stock after July sale Stock TitanView source ↗Stock TitanAug 17, 2026neutral00.6
Cerus (CERS) Stock Sinks As Margin Pressure Deepens Despite Revenue Growth - Simply Wall StreetCerus (CERS) Stock Sinks As Margin Pressure Deepens Despite Revenue Growth Simply Wall StreetView source ↗Simply Wall StreetAug 1, 2026neutral00.6
Cerus Corp (NASDAQ:CERS) Drops 10% After Q2 Revenue Beat Overshadowed by Lowered Full-Year Guidance - ChartMillCerus Corp (NASDAQ:CERS) Drops 10% After Q2 Revenue Beat Overshadowed by Lowered Full-Year Guidance ChartMillView source ↗ChartMillJul 30, 2026neutral00.6
Cerus CFO Kevin Green sells $99,105 in CERS shares - Investing.comCerus CFO Kevin Green sells $99,105 in CERS shares Investing.comView source ↗Investing.comJul 2, 2026neutral00.6
Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG - Yahoo FinanceCerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG Yahoo FinanceView source ↗Yahoo FinanceMay 23, 2026neutral00.6
Cerus Stock Jumps As Q1 Beat, France Deal And Upgrade Shift Outlook - Timothy SykesCerus Stock Jumps As Q1 Beat, France Deal And Upgrade Shift Outlook Timothy SykesView source ↗Timothy SykesMay 2, 2026neutral00.6
Cerus (CERS) Jumps On Earnings Beat And Major French Deal - StocksToTradeCerus (CERS) Jumps On Earnings Beat And Major French Deal StocksToTradeView source ↗StocksToTradeMay 1, 2026neutral00.6
Cerus (CERS) Q1 2026 Earnings Transcript - The Motley FoolCerus (CERS) Q1 2026 Earnings Transcript The Motley FoolView source ↗The Motley FoolApr 30, 2026neutral00.6
Cerus Corporation (CERS) Stock Rises on Q4 2025 Earnings - Quiver QuantitativeCerus Corporation (CERS) Stock Rises on Q4 2025 Earnings Quiver QuantitativeView source ↗Quiver QuantitativeMar 2, 2026neutral00.6
Cerus Corporation Common Stock (CERS) Stock Price: Oct 15 Close $2.26 - GotradeCerus Corporation Common Stock (CERS) Stock Price: Oct 15 Close $2.26 GotradeView source ↗GotradeJan 13, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.